Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Privacy legislation should not amend current IRB regs, PhRMA testifies at House hearing on Condit bill.

Executive Summary

MEDICAL RECORDS PRIVACY LEGISLATION SHOULD NOT AMEND IRB REVIEW REGS, PhRMA maintained at a June 5 hearing of the House Government Reform/Government Management, Information & Technology Subcommittee. Glaxo Wellcome Worldwide Epidemiology Director Elizabeth Andrews testified on behalf of the Pharmaceutical Research & Manufacturers of America at the hearing, which was called by Subcommittee Chairman Rep. Horn (R-Calif.) to discuss privacy legislation introduced by Rep. Condit (D-Calif.) this session as HR 52.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030337

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel